P

Inventor

SCHILLING WALTER

CH23 patents
⚠️ This page may combine multiple inventors who share the name “SCHILLING WALTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CIBA GEIGY CORP

19 patents
US5559111ASep 24, 1996

δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides

CIBA GEIGY CORP153 citations98
US5646143AJul 8, 1997

δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides

CIBA GEIGY CORP35 citations95
US5310743AMay 10, 1994

1-acylpiperidine compounds

CIBA GEIGY CORP61 citations95
US5627182AMay 6, 1997

δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides

CIBA GEIGY CORP41 citations94
US5654445AAug 5, 1997

δ-amino-γ-hydroxy-ω-aryl-alkanoic acids

CIBA GEIGY CORP27 citations92
US5646144AJul 8, 1997

1-acylpiperidine compounds

CIBA GEIGY CORP28 citations91
US5541195AJul 30, 1996

1-acylpiperidine compounds

CIBA GEIGY CORP27 citations91
US4259338AMar 31, 1981

Benzofuranyl-tetrahydropyridines and -piperidines, their acid addition salts and antidepressant preparations thereof

CIBA GEIGY CORP28 citations81
US4418200ANov 29, 1983

Tricyclic imidyl derivatives

CIBA GEIGY CORP3 citations74
US4337200AJun 29, 1982

Tricyclic imidyl derivatives

CIBA GEIGY CORP3 citations74
US4242264ADec 30, 1980

Tricyclic imidyl derivatives

CIBA GEIGY CORP6 citations74
US5604247AFeb 18, 1997

Chromone Derivatives

CIBA GEIGY CORP11 citations72
US4424366AJan 3, 1984

Tricyclic imidyl derivatives

CIBA GEIGY CORP1 citations63
US4417058ANov 22, 1983

Tricyclic imidyl derivatives

CIBA GEIGY CORP1 citations63
US4487942ADec 11, 1984

6,7-Dihydro-5H-benzocycloheptene-8,9-dicarboxylic acid anhydrides

CIBA GEIGY CORP0 citations52
US4486596ADec 4, 1984

2,3-Dihydro-1-benzoxepine-4,5-dicarboxylic acid anhydrides

CIBA GEIGY CORP0 citations52
US4423231ADec 27, 1983

Tricyclic imidyl derivatives

CIBA GEIGY CORP0 citations52
US4418199ANov 29, 1983

Tricyclic imidyl derivatives

CIBA GEIGY CORP0 citations52
US4414394ANov 8, 1983

Tricyclic imidyl derivatives

CIBA GEIGY CORP0 citations52

NOVARTIS AG

3 patents

SYNAPTIC PHARMA CORP

1 patent